Angion Biomedica Receives Fast Track and Orphan Drug Product Designations from FDA for its Lead Therapeutic, BB3
July 6, 2010
  |
|
|
     |
       |
|
|||||||||
| Home | Company | Products | Technology | Careers | Contact Us |